year
111Category: | Intermediates/Pharmaceutical intermediates |
|
|
CAS NO: | 202138-50-9 | ||
EC NO: | |||
Molecular Formula: | C23H34N5O14P | ||
Molecular Weight: | 635.5149 | ||
Specification: | 99% min | ||
InChI: | InChI=1/C19H30N5O10P.C4H4O4/c1-12(2)33-18(25)28-9-31-35(27,32-10-29-19(26)34-13(3)4)11-30-14(5)6-24-8-23-15-16(20)21-7-22-17(15)24;5-3(6)1-2-4(7)8/h7-8,12-14H,6,9-11H2,1-5H3,(H2,20,21,22);1-2H,(H,5,6)(H,7,8)/b;2-1+/t14-;/m1./s1 | ||
Product description: Tenofovir disoproxil fumarate CAS 202138-50-9 Assay:99%min Synonyms: Tenofovir disoproxil fumarate TENOFOVIR DISOPROXIC 9-((R)-2-((Bis(((isopropoxycarbonyl)oxy)methoxy)phosphinyl)methoxy)propyl)adenine fumarate Molecular Formula: C19H30N5O10P Molecular Weight: 635.51 |
|||
Synonyms: | 9-((R)-2-((Bis(((isopropoxycarbonyl)oxy)methoxy)phosphinyl)methoxy)propyl)adenine fumarate;bis({[(1-methylethoxy)carbonyl]oxy}methyl) {[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl}phosphonate (2E)-but-2-enedioate;Tenofovir Disproxil Fumarate;Tenofovir Dipivoxil Fumarate; | ||
Molecular Structure: |